|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-12-19
|
|
pubmed:abstractText |
Single-agent platinum and single-agent pegylated liposomal doxorubicin (PLD) are both effective in the treatment of gynecologic malignancies. Based on evidence that combination platinum-containing regimens offer superior efficacy versus single-agent regimens, we conducted this study to determine the maximum tolerated dose (MTD) of PLD in combination with carboplatin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe...,
pubmed-author:BurgesAA,
pubmed-author:ElseaVV,
pubmed-author:JackischCC,
pubmed-author:KimmigRR,
pubmed-author:MeierWW,
pubmed-author:PfistererJJ,
pubmed-author:RichterBB,
pubmed-author:SchmalfeldtBB,
pubmed-author:StaehleAA,
pubmed-author:du BoisAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16282248-Adult,
pubmed-meshheading:16282248-Aged,
pubmed-meshheading:16282248-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16282248-Area Under Curve,
pubmed-meshheading:16282248-Carboplatin,
pubmed-meshheading:16282248-Dose-Response Relationship, Drug,
pubmed-meshheading:16282248-Doxorubicin,
pubmed-meshheading:16282248-Endometrial Neoplasms,
pubmed-meshheading:16282248-Female,
pubmed-meshheading:16282248-Humans,
pubmed-meshheading:16282248-Maximum Tolerated Dose,
pubmed-meshheading:16282248-Middle Aged,
pubmed-meshheading:16282248-Ovarian Neoplasms,
pubmed-meshheading:16282248-Polyethylene Glycols,
pubmed-meshheading:16282248-Prospective Studies,
pubmed-meshheading:16282248-Sarcoma,
pubmed-meshheading:16282248-Survival Rate,
pubmed-meshheading:16282248-Uterine Cervical Neoplasms
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).
|
|
pubmed:affiliation |
HSK, Dr Horst Schmidt Klinik, Department of Gynecology & Gynecologic Oncology, Wiesbaden, Germany. dubois.hsk-wiesbaden@uumail.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
